-
Something wrong with this record ?
Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells
J Prochazkova, J Fric, K Pokorna, A Neuwirth, M Krulova, A Zajicova, V Holan
Language English Country Great Britain
Document type Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1958 to 1 year ago
PubMed Central
from 1958 to 2021
Medline Complete (EBSCOhost)
from 1958-01-01 to 1 year ago
Wiley Online Library (archiv)
from 1996-01-01 to 2012-12-31
Wiley Free Content
from 1996 to 1 year ago
- MeSH
- Cell Differentiation immunology drug effects MeSH
- CD4-Positive T-Lymphocytes immunology metabolism drug effects MeSH
- Forkhead Transcription Factors antagonists & inhibitors biosynthesis MeSH
- Interleukin-4 pharmacology physiology MeSH
- RNA, Messenger immunology metabolism MeSH
- Mice, Inbred BALB C MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- T-Lymphocyte Subsets immunology drug effects immunology metabolism drug effects MeSH
- Transforming Growth Factor beta pharmacology physiology MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
The development and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) are strictly regulated by cytokines. Here we show that transforming growth factor-beta (TGF-beta) and interleukin-4 (IL-4) play a crucial and antagonistic role in the development of Tregs. Additionally, these cytokines also have distinct effects on the maintenance of natural (nTregs) and antigen-induced (iTregs) Tregs. Using double-staining and tracking of proliferation of purified and carboxyflourescein succinimidyl ester (CFSE)-labelled mouse T-cell subpopulations we demonstrated that CD4(+) CD25(+) Foxp3(+) iTregs develop upon alloantigenic stimulation in the presence of TGF-beta exclusively from CD4(+) CD25(-) Foxp3(-) precursors. Both the induction of Foxp3 expression and Treg proliferation were prevented when the cells were stimulated in the presence of IL-4. By contrast, nTregs did not proliferate in the presence of the antigen and TGF-beta, and partially lost their Foxp3 expression. IL-4 not only prevented the development of iTregs, but also down-regulated the level of Foxp3 mRNA and decreased the number of Foxp3(+) cells in a population of iTregs. Further analyses proved that IL-4 decreased the expression of Foxp3 only in a population of iTregs, whereas it substantially supported the survival of nTregs. Functional experiments showed that Tregs induced in the presence of alloantigen and TGF-beta inhibited, on a per-cell basis, cell proliferation comparably to nTregs, and their suppressive capacity was not modulated by IL-4. These data suggest that TGF-beta and IL-4 differentially regulate the development of Tregs and distinctly sustain Foxp3 expression and the number of nTregs and iTregs, but have no influence on the suppressive activity of Tregs on a per-cell basis.
- 000
- 04086naa a2200565 a 4500
- 001
- bmc12008627
- 003
- CZ-PrNML
- 005
- 20141107090246.0
- 008
- 120316s2009 xxk eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Procházková, Jana $u Institute of Molecular Genetics, Academy of Sciences, Videnska, Prague, Czech Republic. $7 _AN080449
- 245 10
- $a Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells / $c J Prochazkova, J Fric, K Pokorna, A Neuwirth, M Krulova, A Zajicova, V Holan
- 520 9_
- $a The development and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) are strictly regulated by cytokines. Here we show that transforming growth factor-beta (TGF-beta) and interleukin-4 (IL-4) play a crucial and antagonistic role in the development of Tregs. Additionally, these cytokines also have distinct effects on the maintenance of natural (nTregs) and antigen-induced (iTregs) Tregs. Using double-staining and tracking of proliferation of purified and carboxyflourescein succinimidyl ester (CFSE)-labelled mouse T-cell subpopulations we demonstrated that CD4(+) CD25(+) Foxp3(+) iTregs develop upon alloantigenic stimulation in the presence of TGF-beta exclusively from CD4(+) CD25(-) Foxp3(-) precursors. Both the induction of Foxp3 expression and Treg proliferation were prevented when the cells were stimulated in the presence of IL-4. By contrast, nTregs did not proliferate in the presence of the antigen and TGF-beta, and partially lost their Foxp3 expression. IL-4 not only prevented the development of iTregs, but also down-regulated the level of Foxp3 mRNA and decreased the number of Foxp3(+) cells in a population of iTregs. Further analyses proved that IL-4 decreased the expression of Foxp3 only in a population of iTregs, whereas it substantially supported the survival of nTregs. Functional experiments showed that Tregs induced in the presence of alloantigen and TGF-beta inhibited, on a per-cell basis, cell proliferation comparably to nTregs, and their suppressive capacity was not modulated by IL-4. These data suggest that TGF-beta and IL-4 differentially regulate the development of Tregs and distinctly sustain Foxp3 expression and the number of nTregs and iTregs, but have no influence on the suppressive activity of Tregs on a per-cell basis.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a CD4-pozitivní T-lymfocyty $x imunologie $x metabolismus $x účinky léků $7 D015496
- 650 02
- $a buněčná diferenciace $x imunologie $x účinky léků $7 D002454
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a forkhead transkripční faktory $x antagonisté a inhibitory $x biosyntéza $7 D051858
- 650 02
- $a interleukin-4 $x farmakologie $x fyziologie $7 D015847
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a myši $7 D051379
- 650 02
- $a myši inbrední BALB C $7 D008807
- 650 02
- $a myši inbrední C57BL $7 D008810
- 650 02
- $a messenger RNA $x imunologie $x metabolismus $7 D012333
- 650 02
- $a T-lymfocyty - podskupiny $x imunologie $x účinky léků $7 D016176
- 650 02
- $a T-lymfocyty - podskupiny $x imunologie $x metabolismus $x účinky léků $7 D016176
- 650 02
- $a transformující růstový faktor beta $x farmakologie $x fyziologie $7 D016212
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Frič, Jan $7 xx0106155
- 700 1_
- $a Pokorná, Kateřina $7 xx0140490
- 700 1_
- $a Neuwirth, Aleš $7 xx0108965
- 700 1_
- $a Krulová, Magdaléna $7 xx0083610
- 700 1_
- $a Zajícová, Alena $7 xx0105272
- 700 1_
- $a Holáň, Vladimír, $d 1950- $7 nlk20050169384
- 773 0_
- $t Immunology $p Immunology $g Roč. 128, č. 1 Suppl (2009), s. e670-e678 $w MED00009850 $x 0172-6390
- 773 0_
- $p Immunology $g 128(1 Suppl):e670-8, 2009 Sep
- 910 __
- $a ABA008 $b x $y 4 $z 0
- 990 __
- $a 20120319124554 $b ABA008
- 991 __
- $a 20141107090256 $b ABA008
- 999 __
- $a ok $b bmc $g 901974 $s 765522
- BAS __
- $a 3
- BMC __
- $a 2009 $b 128 $c 1 Suppl $d e670-e678 $m Immunology $x MED00009850
- LZP __
- $a 2012-1Q10/